These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22362302)

  • 1. Quantification of ZAP-70 mRNA by real-time PCR is a prognostic factor in chronic lymphocytic leukemia.
    Wang YH; Zou ZJ; Liu L; Zhang LN; Fang C; Zhu DX; Fan L; Li JY; Xu W
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):1011-7. PubMed ID: 22362302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia.
    Stamatopoulos B; Meuleman N; Haibe-Kains B; Duvillier H; Massy M; Martiat P; Bron D; Lagneaux L
    Clin Chem; 2007 Oct; 53(10):1757-66. PubMed ID: 17702857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
    Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
    Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia.
    Buhl AM; Jurlander J; Geisler CH; Pedersen LB; Andersen MK; Josefsson P; Petersen JH; Leffers H
    Eur J Haematol; 2006 Jun; 76(6):455-64. PubMed ID: 16529606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia.
    Oppezzo P; Vasconcelos Y; Settegrana C; Jeannel D; Vuillier F; Legarff-Tavernier M; Kimura EY; Bechet S; Dumas G; Brissard M; Merle-Béral H; Yamamoto M; Dighiero G; Davi F;
    Blood; 2005 Jul; 106(2):650-7. PubMed ID: 15802535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia.
    Van Bockstaele F; Pede V; Janssens A; Callewaert F; Offner F; Verhasselt B; Philippé J
    Clin Chem; 2007 Feb; 53(2):204-12. PubMed ID: 17158192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
    Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
    N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status.
    Plesingerova H; Librova Z; Plevova K; Libra A; Tichy B; Skuhrova Francova H; Vrbacky F; Smolej L; Mayer J; Bryja V; Doubek M; Pospisilova S
    Leuk Lymphoma; 2017 Jan; 58(1):70-79. PubMed ID: 27185377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic nucleotide phosphodiesterase 7B mRNA: an unfavorable characteristic in chronic lymphocytic leukemia.
    Zhang L; Murray F; Rassenti LZ; Pu M; Kelly C; Kanter JR; Greaves A; Messer K; Kipps TJ; Insel PA
    Int J Cancer; 2011 Sep; 129(5):1162-9. PubMed ID: 21120911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
    Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
    Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor.
    Zanotti R; Ambrosetti A; Lestani M; Ghia P; Pattaro C; Remo A; Zanetti F; Stella S; Perbellini O; Prato G; Guida G; Caligaris-Cappio F; Menestrina F; Pizzolo G; Chilosi M
    Leukemia; 2007 Jan; 21(1):102-9. PubMed ID: 17082778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kolmogorov-Smirnov statistical test for analysis of ZAP-70 expression in B-CLL, compared with quantitative PCR and IgV(H) mutation status.
    Van Bockstaele F; Janssens A; Piette A; Callewaert F; Pede V; Offner F; Verhasselt B; Philippé J
    Cytometry B Clin Cytom; 2006 Jul; 70(4):302-8. PubMed ID: 16906582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometry.
    Adams RL; Cheung C; Banh R; Saal R; Cross D; Gill D; Self M; Klein K; Mollee P
    Cytometry B Clin Cytom; 2014 Mar; 86(2):80-90. PubMed ID: 24127306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment.
    Morabito F; Cutrona G; Mosca L; D'Anca M; Matis S; Gentile M; Vigna E; Colombo M; Recchia AG; Bossio S; De Stefano L; Maura F; Manzoni M; Ilariucci F; Consoli U; Vincelli I; Musolino C; Cortelezzi A; Molica S; Ferrarini M; Neri A
    Leuk Res; 2015 Aug; 39(8):840-5. PubMed ID: 26038121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors for chronic lymphocytic leukemia with typical and atypical immunophenotype].
    Cao X; Xu W; Wu YJ; Qiao C; Liu Q; Fan L; Miao KR; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jul; 30(7):450-3. PubMed ID: 19954596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of serum immunoglobulin paraprotein in patients with chronic lymphocytic leukemia.
    Xu W; Wang YH; Fan L; Fang C; Zhu DX; Wang DM; Qiao C; Wu YJ; Li JY
    Leuk Res; 2011 Aug; 35(8):1060-5. PubMed ID: 21208658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of lymphocyte-activation gene 3 (LAG3) in chronic lymphocytic leukemia cells is associated with unmutated immunoglobulin variable heavy chain region (IGHV) gene and reduced treatment-free survival.
    Kotaskova J; Tichy B; Trbusek M; Francova HS; Kabathova J; Malcikova J; Doubek M; Brychtova Y; Mayer J; Pospisilova S
    J Mol Diagn; 2010 May; 12(3):328-34. PubMed ID: 20228263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia.
    Shi K; Sun Q; Qiao C; Zhu H; Wang L; Wu J; Wang L; Fu J; Young KH; Fan L; Xia Y; Xu W; Li J
    Cancer Med; 2020 Feb; 9(3):999-1007. PubMed ID: 31849198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
    Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
    Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.